These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 14518255)

  • 1. [Detection of H-ras and K-ras in tumors of gastrointestinal-pancreatic system].
    Liedke M; Karnbach C; Kalinin V; Herbst B; Frilling A; Broelsch CE
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):255-9. PubMed ID: 14518255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
    Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
    Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J; Niu J; Li M; Chiao PJ; Tsao MS
    Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis.
    Wang DG; Johnston CF; Buchanan KD
    Cancer; 1997 Aug; 80(4):668-75. PubMed ID: 9264349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An anti-K-ras ribozyme suppresses oncogene expression and cell growth of human pancreatic cancer.
    Sakuma T; Kijima H; Nishi M; Abe Y; Yamazaki H; Mine T; Nakamura M; Ueyama Y
    Tokai J Exp Clin Med; 2004 Jun; 29(2):35-42. PubMed ID: 15473338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
    Jiang K; Delarue FL; Sebti SM
    Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of K-ras point mutation at codon 12 in pancreatic diseases: a study in a Brazilian casuistic.
    Kubrusly MS; Cunha JE; Bacchella T; Abdo EE; Jukemura J; Penteado S; Morioka CY; de Souza LJ; Machado MC
    JOP; 2002 Sep; 3(5):144-51. PubMed ID: 12221329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis CG; Caplin ME
    Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of hepatic micrometastasis in ductal pancreatic carcinoma by K-ras mutation analysis and determination of clinical relevance].
    Bastian D; Gerdes B; Ramaswamy A; Tschammer C; Bartsch D
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):45-7. PubMed ID: 14518210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas.
    Hrasćan R; Pećina-Slaus N; Martić TN; Colić JF; Gall-Troselj K; Pavelić K; Karapandza N
    J Neuroendocrinol; 2008 Aug; 20(8):1015-22. PubMed ID: 18510707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and co-expression of cellular oncogenes in the course of tumor progression in neuroendocrine lung tumors].
    Kogan EA; Shtabskiĭ AB; Sekamova SM; Sukhova NM; Mazurenko NN
    Arkh Patol; 1994; 56(2):16-21. PubMed ID: 8037585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frequency of K-ras mutation in biliary and pancreatic tumors].
    Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
    Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract.
    Arvidsson Y; Andersson E; Bergström A; Andersson MK; Altiparmak G; Illerskog AC; Ahlman H; Lamazhapova D; Nilsson O
    Endocr Relat Cancer; 2008 Jun; 15(2):569-81. PubMed ID: 18430897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-entero-pancreatic system.
    Arnold CN; Sosnowski A; Schmitt-Gräff A; Arnold R; Blum HE
    Int J Cancer; 2007 May; 120(10):2157-64. PubMed ID: 17278096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where and when does pancreatic carcinoma start?
    Lüttges J; Hahn S; Klöppel G
    Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.
    Rindi G; Candusso ME; Solcia E
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S135-8. PubMed ID: 10604117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NFKB1 -94 insertion/deletion ATTG polymorphism in gastroenteropancreatic neuroendocrine tumors.
    Burnik FS; Yalçin S
    Chemotherapy; 2009; 55(5):381-5. PubMed ID: 19752553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine- and amphetamine-regulated transcript in neuroendocrine tumors.
    Landerholm K; Falkmer SE; Järhult J; Sundler F; Wierup N
    Neuroendocrinology; 2011; 94(3):228-36. PubMed ID: 21832817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
    Rindi G; Villanacci V; Ubiali A
    Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells.
    Agbunag C; Bar-Sagi D
    Cancer Res; 2004 Aug; 64(16):5659-63. PubMed ID: 15313904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.